Latest News about GILD

Recent news which mentions GILD

...

26 27 28 29 30 31 32 33 Next >

10 Health Care Stocks With Whale Alerts In Today's Session

January 12, 2022

7 Safe Stocks for Your Retirement

January 07, 2022

This ‘cash cow’ value-stock strategy can fatten your portfolio even if you fear the Fed

January 06, 2022

What 5 Analyst Ratings Have To Say About Gilead Sciences

January 06, 2022

Benzinga's Top Ratings Upgrades, Downgrades For January 6, 2022

January 06, 2022

10 Biggest Price Target Changes For Thursday

January 06, 2022

7 Pharmaceutical Stocks That Could Make You Rich

January 06, 2022

2 Top Dividend Stocks That Are Yielding More Than 3%

January 05, 2022

23 dividend stocks that can pass this strict quality screen

January 04, 2022

3 Biotech Stocks That Could Double in 2022

January 03, 2022

Two Paths to End the Pandemic but the Hybrid Approach Looks Dominant

December 29, 2021

NRXP Stock Alert: What Is Going on With NRx Pharmaceuticals Today?

December 29, 2021

Mobile Clinics for Mental Health Treatments Reportedly Launching in Major Cities Across the U.S.

December 28, 2021

Got $5,000? Buy and Hold These 3 Value Stocks for Years

December 24, 2021

The Daily Biotech Pulse: Novartis Snags Twin FDA Nods, Novavax Positive Vaccine News Continues, Arcutis Psoriasis Application Accepted For Review

December 23, 2021

Gilead's Remdesivir Shows Consistent Efficacy In Patients With Comorbidities With Higher Risk for Severe COVID-19

December 23, 2021

Price To Earnings Ratio Insights For Gilead Sciences

December 22, 2021

FDA Slaps Clinical Hold On Gilead's Injectable Lenacapavir In HIV Trials

December 22, 2021

The Daily Biotech Pulse: Allakos Slips Negative Late-Stage Data, Pfizer & Merck Announce Fresh COVID Pill Deal With UK, Regulatory Setback For Takeda

December 22, 2021

European Commission Expands Use Of Remdesivir In COVID-19 Patients Not On Supplemental Oxygen

December 21, 2021

EMA Might Not Decide On Merck's COVID-91 Oral Antiviral Before Christmas: Reuters

December 17, 2021

Gilead's CAR-T Yescarta Shows 78% Complete Response Rate In First-Line Lymphoma Patients

December 14, 2021

Gilead's Kite Unveils More Data On Yescarta In Second-Line Lymphoma Patients

December 13, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 9, 2021

December 09, 2021

Why Arcus Biosciences Stock Vaulted Higher in November

December 09, 2021

Is Gilead Sciences Stock a Buy Now?

December 07, 2021

The Daily Biotech Pulse: Acadia Jumps On Data, vTv Shelves Psoriasis Study, More Setbacks For Merck's HIV Program, Decision Day For Daré

December 07, 2021

Benzinga's Top Ratings Upgrades, Downgrades For December 6, 2021

December 06, 2021

The Week Ahead In Biotech (Dec. 6-Dec. 11): Daré FDA Decision, Adcom Tryst For Reata, Multiple Conference Presentations And More

December 06, 2021

Gilead Recalls Two Lots Of Remdesivir Due To Presence Of Glass Particulates

December 06, 2021

...

26 27 28 29 30 31 32 33 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.